On the convalescent blood plasma

The Palace welcomes the announcement of Department of Science and Technology (DOST) Secretary Fortunato T. de la Peña on the start of the government-funded study looking on the use of convalescent blood plasma as one of the modes of therapy for Covid-19.

The use of convalescent plasma as adjunctive therapy for patients hospitalized for COVID-19 is being undertaken by the University of the Philippines-Philippine General Hospital, with funding support from the DOST.

We note that the study is banking on the use of convalescent plasma taken from the blood of patients who have recovered from the infection, and therefore contains neutralizing antibodies against the virus.

We hope this study will yield positive results and be our country’s contribution to the global effort to develop COVID-19 treatment.